2014
Big Data In Health Care: Using Analytics To Identify And Manage High-Risk And High-Cost Patients
Bates D, Saria S, Ohno-Machado L, Shah A, Escobar G. Big Data In Health Care: Using Analytics To Identify And Manage High-Risk And High-Cost Patients. Health Affairs 2014, 33: 1123-1131. PMID: 25006137, DOI: 10.1377/hlthaff.2014.0041.Commentaries, Editorials and LettersConceptsBig dataClinical analyticsPrivacy concernsUse casesElectronic health recordsAnalyticsTypes of dataHealth recordsTypes of insightsNecessary analysisSupport of researchHigh-cost patientsUnprecedented opportunityMonitoring devicesCostHealth careAlgorithmMultiple organ systemsRapid progressInfrastructureUS health care systemHealth care systemSystemAdverse eventsClinical data
2008
Validation of an Automated Safety Surveillance System with Prospective, Randomized Trial Data
Matheny M, Morrow D, Ohno-Machado L, Cannon C, Sabatine M, Resnic F. Validation of an Automated Safety Surveillance System with Prospective, Randomized Trial Data. Medical Decision Making 2008, 29: 247-256. PMID: 19015285, PMCID: PMC2743924, DOI: 10.1177/0272989x08327110.Peer-Reviewed Original ResearchMeSH KeywordsBayes TheoremData Interpretation, StatisticalDecision Support TechniquesFibrinolytic AgentsHumansIntracranial HemorrhagesMulticenter Studies as TopicMyocardial InfarctionRandomized Controlled Trials as TopicReproducibility of ResultsRetrospective StudiesSafety ManagementSentinel SurveillanceConceptsIntervention armMortality rateEvent ratesTrial BTrial AMajor bleeding ratesOutcomes Surveillance SystemIntracranial hemorrhage rateCumulative event rateRandomized trial dataEvent-rate analysisSafety surveillance systemSurveillance systemAdverse eventsMulticenter trialHemorrhage rateMonth 14Bleeding rateControl armClinical trialsTrial B.Trial dataTrialsObserved event ratesMonths
2003
No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention
Resnic F, Wainstein M, Lee M, Behrendt D, Wainstein R, Ohno-Machado L, Kirshenbaum J, Rogers C, Popma J, Piana R. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. American Heart Journal 2003, 145: 42-46. PMID: 12514653, DOI: 10.1067/mhj.2003.36.Peer-Reviewed Original ResearchConceptsPercutaneous coronary interventionPostprocedural myocardial infarctionStrong independent predictorMyocardial infarctionIndependent predictorsSodium nitroprussideInhospital outcomesCoronary interventionClinical outcomesSaphenous vein graft interventionIntracoronary vasodilator therapyVein graft interventionAdministration of verapamilAcute myocardial infarctionRate of deathInhospital mortalityVasodilator therapyCardiogenic shockBaseline demographicsGraft interventionUnstable anginaAdverse eventsConsecutive patientsIntracoronary verapamilInfarction